Christian Kowol and Petra Heffeter won the first place in the category "Liefe Sciences" for the development of a new tyrosine‐kinase inhibitor.
Scientists of the Research Platform "Translational Cancer Therapy Research" were able to publish promising results about a new tyrosine‐kinase...
The 7th International Symposium on Bioorganometallic Chemistry will be held at the University of Vienna July 22-25 2014
Members of the Research Platform "Translational Cancer Therapy Research" met with Sidney Altman on the occasion of the 7th Vienna Seminar of Nobel...
NKP-1339: A promising new anti-cancer drug that has recently been successfully tested on patients.
A Phase I clinical study conducted in the USA has shown the cancer-inhibiting effect and good tolerability of the ruthenium compound NKP1339/IT-139,...
